Buscar resultados de ensayos clínicos
Papilledema - 16 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: aICP in Glaucoma and Papilledema Condición:
Fecha: 2015-03-23 Intervenciones: Device: Non-invasive ICP measurement (Vittamed 305) The non-invasive method is based on two-depth TCD te |
Not yet recruiting |
Nombre del estudio: Ocular Point of Care Ultrasound (POCUS) to Detect Optic Disc Swelling in Comparison to Ophthalmologic Examination Condición: Papilledema Associated With Increased Intracranial Pressure Fecha: 2016-12-05 Intervenciones: Device: Point of care ocular ultrasound |
Recruiting |
Nombre del estudio: Antiacne Medications Pseudotumor Cerebri Condición: Optic Disc Swelling Fecha: 2014-04-07 Intervenciones: Other: Retinal nerve fibre layer measurement Measurement of retinal nerve fibre layer thickness using op |
Completed |
Nombre del estudio: Assessment of Retinal Nerve Fibre Layer by Optical Coherence Tomography in Uveitis Patients With Papilloedema Condición:
Fecha: 2010-07-21 |
Terminated |
Nombre del estudio: Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease Condición:
|
Not yet recruiting |
Nombre del estudio: OCT Imaging of Papilledema in Pediatric Idiopathic Intracranial Hypertension Condición: Pediatric Idiopathic Intracranial Hypertension Fecha: 2016-01-24 Intervenciones: Other: OCT Imaging |
Recruiting |
Nombre del estudio: Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery Condición:
Fecha: 2013-04-16 Intervenciones:
|
Available |
Nombre del estudio: A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic Retinal Edema Condición: Diabetic Macular Edema Fecha: 2011-12-05 Intervenciones: Drug: Macugen (Pegaptanib Sodium) Pegaptanib sodium drug s |
Not yet recruiting |
Nombre del estudio: Efficacy of Biweekly Ranibizumab (0.5 mg) for Exudative Macular Degeneration Retinal Edema Refractory to Anti-VEGF Condición: Exudative Age Related Macular Degeneration Fecha: 2017-02-24 Intervenciones: Drug: Ranibizumab Injection [Lucentis] intravitreal injection |
Completed |
Nombre del estudio: Ozurdex for Macular Edema Post Membrane Peeling Condición:
|